<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>00855574003045</udiDi>
    <basicUdiDi>B-00855574003045</basicUdiDi>
    <tradeName>KXL System</tradeName>
    <deviceName>KXL System</deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>Q0299</emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>110-01019</reference>
    <placedOnMarketCountry>Italy</placedOnMarketCountry>
    <lastUpdated>2026-07-05T08:28:46.125Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003168</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Accelerated Epi-Off Treatment (10Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EP-004365</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:25.101Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003175</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Accelerated Epi-Off Treatment (1Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>520-004391</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:25.078Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003182</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Conventional Epi-Off Treatment (10Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EP-004461</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:25.058Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003199</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Conventional Epi-Off Treatment (1Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>520-004468</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:25.035Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003205</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Lasik Xtra Treatment (10Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EP-004363</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:25.007Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003212</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Lasik Xtra Treatment (1Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>520-004393</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:24.988Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003229</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Trans-Epithelial Treatment (10Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>EP-004369</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:24.969Z</lastUpdated>
  </row>
  <row>
    <udiDi>00855574003236</udiDi>
    <basicUdiDi>085557400310003EH</basicUdiDi>
    <tradeName>Trans-Epithelial Treatment (1Tx)</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Avedro, a Glaukos Company</manufacturerName>
    <manufacturerSrn>US-MF-000038119</manufacturerSrn>
    <authorisedRepresentativeName>Glaukos Netherlands B.V.</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>NL-AR-000002685</authorisedRepresentativeSrn>
    <riskClass>Sınıf I</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>OPHTHALMIC DEVICES - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>520-004396</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-21T20:19:24.948Z</lastUpdated>
  </row>
</eudamedExport>